TickerFacts.

Dianthus Therapeutics, Inc. (DNTH): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$27.78M
Year ended 2022-12-31
2016-12-31: -$9.26M2017-12-31: -$35.35M2018-12-31: -$59.09M2019-12-31: -$81.13M2020-12-31: -$76.72M2021-12-31: -$72.67M2022-12-31: -$27.78M-$27.78M
2016-12-31 EBITDA (USD) 2022-12-31
Period endedEBITDAChange YoYSource filing
2022-12-31-$27.78Mn/m2024-03-21, From 2022-01-01
2021-12-31-$72.67Mn/m2023-03-23, From 2021-01-01
2020-12-31-$76.72Mn/m2022-03-08, From 2020-01-01
2019-12-31-$81.13Mn/m2021-03-03, From 2019-01-01
2018-12-31-$59.09Mn/m2020-03-03, From 2018-01-01
2017-12-31-$35.35Mn/m2020-03-03, From 2017-01-01
2016-12-31-$9.26Mn/a2019-03-19, From 2016-01-01